Last reviewed · How we verify

NCT03544541

Cardiometabolic Risk in Children With Type 1 Diabetes.

Completed Last updated 5 February 2020
What this trial tests

trial in Type1 Diabetes Mellitus in 150 participants. Completed in 30 November 2019.

Timeline
5 January 2018
Primary endpoint
30 November 2019
30 November 2019

Quick facts

Lead sponsorUniversity of Ljubljana, Faculty of Medicine
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date5 January 2018
Primary completion30 November 2019
Estimated completion30 November 2019
Sites1 location across Slovenia

Conditions studied

Sponsor

University of Ljubljana, Faculty of Medicine

Who can join

Adults 10 to 25, any sex, with Type1 Diabetes Mellitus or Metabolic Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To access the relationship between metabolic control of children and adolescents with type 1 diabetes and cardiometabolic risk through noninvasive imaging modalities to assess the early vasculature changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type1 Diabetes Mellitus

Currently open trials in the same condition.

Other University of Ljubljana, Faculty of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03544541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing